Two drugmakers fight against drug price cuts

Guju Pharma and Youngpoong Pharma, small-sized pharmaceutical firms in Korea and the government are at odds over the new regulation slashing drug prices by an average of 14 percent from April 1.

The two drug firms have filed an injunction and annulment suit against the Ministry of Health and Welfare, claiming the government’s improper claim over the correlation of illegal rebates and drug p...